{"entity":{"type":"insider","cik":"0001485508","url":"/insider/0001485508","json_url":"/insider/0001485508.json","name":"Collins Cooper C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":39,"n_filings":20,"first":"2011-07-25","last":"2024-08-26","span_basis":"filed_date"},"name_variants":[{"name":"Collins Cooper C.","source":"filing","n_filings":20,"first_seen":"2011-07-25","last_seen":"2024-08-26"}],"transactions":[{"id":2300138,"accession":"0000905148-24-002363","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-24-002363","line_url":"/filing/0000905148-24-002363#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4094.0,"shares_display":"4,094","price_per_share":1.734,"price_display":"1.73","price_state":"stated","total_value":7098.996,"total_display":"7,099.00","total_whole":"7,099","shares_owned_after":52016.0,"shares_owned_after_display":"52,016","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-22","filed_date":"2024-08-26","scope":"insider"},{"id":2621965,"accession":"0000905148-24-002340","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905148-24-002340","line_url":"/filing/0000905148-24-002340#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200.0,"shares_display":"1,200","price_per_share":1.6988,"price_display":"1.70","price_state":"stated","total_value":2038.56,"total_display":"2,038.56","total_whole":"2,039","shares_owned_after":47922.0,"shares_owned_after_display":"47,922","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-21","filed_date":"2024-08-23","scope":"insider"},{"id":5056388,"accession":"0001209191-21-066002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-066002","line_url":"/filing/0001209191-21-066002#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":0.5785,"price_display":"0.58","price_state":"stated","total_value":578500.0,"total_display":"578,500.00","total_whole":"578,500","shares_owned_after":2236864.0,"shares_owned_after_display":"2,236,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-22","scope":"insider"},{"id":4299657,"accession":"0001387131-21-008733","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-21-008733","line_url":"/filing/0001387131-21-008733#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":900000.0,"shares_display":"900,000","price_per_share":0.72,"price_display":"0.72","price_state":"stated","total_value":648000.0,"total_display":"648,000.00","total_whole":"648,000","shares_owned_after":1236864.0,"shares_owned_after_display":"1,236,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-18","filed_date":"2021-08-19","scope":"insider"},{"id":4299654,"accession":"0001387131-21-008733","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-21-008733","line_url":"/filing/0001387131-21-008733#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.77,"price_display":"0.77","price_state":"stated","total_value":77000.0,"total_display":"77,000.00","total_whole":"77,000","shares_owned_after":336864.0,"shares_owned_after_display":"336,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-17","filed_date":"2021-08-19","scope":"insider"},{"id":2306148,"accession":"0001387131-20-005591","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-20-005591","line_url":"/filing/0001387131-20-005591#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":47500.0,"shares_display":"47,500","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":68875.0,"total_display":"68,875.00","total_whole":"68,875","shares_owned_after":140000.0,"shares_owned_after_display":"140,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-09","filed_date":"2020-06-10","scope":"insider"},{"id":2306141,"accession":"0001387131-20-005591","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-20-005591","line_url":"/filing/0001387131-20-005591#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26500.0,"shares_display":"26,500","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":38425.0,"total_display":"38,425.00","total_whole":"38,425","shares_owned_after":92500.0,"shares_owned_after_display":"92,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-08","filed_date":"2020-06-10","scope":"insider"},{"id":8713797,"accession":"0001387131-19-003731","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-19-003731","line_url":"/filing/0001387131-19-003731#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":3.329,"price_display":"3.33","price_state":"stated","total_value":99870.0,"total_display":"99,870.00","total_whole":"99,870","shares_owned_after":66000.0,"shares_owned_after_display":"66,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-13","filed_date":"2019-05-15","scope":"insider"},{"id":2263171,"accession":"0001387131-16-004575","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-16-004575","line_url":"/filing/0001387131-16-004575#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16000.0,"shares_display":"16,000","price_per_share":6.2323,"price_display":"6.23","price_state":"stated","total_value":99716.8,"total_display":"99,716.80","total_whole":"99,717","shares_owned_after":36000.0,"shares_owned_after_display":"36,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-11","filed_date":"2016-03-14","scope":"insider"},{"id":6564045,"accession":"0001387131-14-002173","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-14-002173","line_url":"/filing/0001387131-14-002173#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":3.8445,"price_display":"3.84","price_state":"stated","total_value":76890.0,"total_display":"76,890.00","total_whole":"76,890","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-05","filed_date":"2014-06-09","scope":"insider"},{"id":6506741,"accession":"0001354488-14-001654","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001354488-14-001654","line_url":"/filing/0001354488-14-001654#line-2","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Officer (Chief Strategic Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategic Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23898.0,"shares_display":"23,898","price_per_share":5.1942,"price_display":"5.19","price_state":"stated","total_value":124130.9916,"total_display":"124,130.99","total_whole":"124,131","shares_owned_after":2500046.0,"shares_owned_after_display":"2,500,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-02","filed_date":"2014-04-02","scope":"insider"},{"id":6506738,"accession":"0001354488-14-001654","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001354488-14-001654","line_url":"/filing/0001354488-14-001654#line-1","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Officer (Chief Strategic Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategic Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66102.0,"shares_display":"66,102","price_per_share":5.279,"price_display":"5.28","price_state":"stated","total_value":348952.458,"total_display":"348,952.46","total_whole":"348,952","shares_owned_after":2523944.0,"shares_owned_after_display":"2,523,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-04-01","filed_date":"2014-04-02","scope":"insider"},{"id":6884519,"accession":"0001354488-14-001012","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001354488-14-001012","line_url":"/filing/0001354488-14-001012","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Officer (Chief Strategic Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategic Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3547195.0,"shares_display":"3,547,195","price_per_share":3.4024693855285655,"price_display":"3.40","price_state":"stated","total_value":12069222.392,"total_display":"12,069,222.39","total_whole":"12,069,222","shares_owned_after":2590046.0,"shares_owned_after_display":"2,590,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-04","filed_date":"2014-03-05","scope":"insider","n_lines":2},{"id":6884511,"accession":"0001354488-14-001012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001354488-14-001012","line_url":"/filing/0001354488-14-001012#line-1","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Officer (Chief Strategic Officer)","role_mark":"O","role_mark_label":"Officer (Chief Strategic Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42805.0,"shares_display":"42,805","price_per_share":3.6105,"price_display":"3.61","price_state":"stated","total_value":154547.4525,"total_display":"154,547.45","total_whole":"154,547","shares_owned_after":6137241.0,"shares_owned_after_display":"6,137,241","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-03","filed_date":"2014-03-05","scope":"insider"},{"id":6537191,"accession":"0001354488-14-000509","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001354488-14-000509","line_url":"/filing/0001354488-14-000509","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14800.0,"shares_display":"14,800","price_per_share":2.6769447972972973,"price_display":"2.68","price_state":"stated","total_value":39618.783,"total_display":"39,618.78","total_whole":"39,619","shares_owned_after":6180046.0,"shares_owned_after_display":"6,180,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-05","filed_date":"2014-02-05","scope":"insider","n_lines":2},{"id":6537185,"accession":"0001354488-14-000509","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001354488-14-000509","line_url":"/filing/0001354488-14-000509#line-2","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42500.0,"shares_display":"42,500","price_per_share":2.1078,"price_display":"2.11","price_state":"stated","total_value":89581.5,"total_display":"89,581.50","total_whole":"89,582","shares_owned_after":6194846.0,"shares_owned_after_display":"6,194,846","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-04","filed_date":"2014-02-05","scope":"insider"},{"id":6537182,"accession":"0001354488-14-000509","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001354488-14-000509","line_url":"/filing/0001354488-14-000509#line-1","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32700.0,"shares_display":"32,700","price_per_share":2.1567,"price_display":"2.16","price_state":"stated","total_value":70524.09,"total_display":"70,524.09","total_whole":"70,524","shares_owned_after":6237346.0,"shares_owned_after_display":"6,237,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-03","filed_date":"2014-02-05","scope":"insider"},{"id":6445036,"accession":"0001354488-14-000098","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001354488-14-000098","line_url":"/filing/0001354488-14-000098#line-1","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27962.0,"shares_display":"27,962","price_per_share":2.2034,"price_display":"2.20","price_state":"stated","total_value":61611.4708,"total_display":"61,611.47","total_whole":"61,611","shares_owned_after":6270046.0,"shares_owned_after_display":"6,270,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-07","filed_date":"2014-01-08","scope":"insider"},{"id":6685202,"accession":"0001354488-14-000060","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001354488-14-000060","line_url":"/filing/0001354488-14-000060#line-3","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28443.0,"shares_display":"28,443","price_per_share":2.2306,"price_display":"2.23","price_state":"stated","total_value":63444.9558,"total_display":"63,444.96","total_whole":"63,445","shares_owned_after":6298008.0,"shares_owned_after_display":"6,298,008","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-06","filed_date":"2014-01-06","scope":"insider"},{"id":6685199,"accession":"0001354488-14-000060","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001354488-14-000060","line_url":"/filing/0001354488-14-000060#line-2","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6195.0,"shares_display":"6,195","price_per_share":2.4185,"price_display":"2.42","price_state":"stated","total_value":14982.6075,"total_display":"14,982.61","total_whole":"14,983","shares_owned_after":6326451.0,"shares_owned_after_display":"6,326,451","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-03","filed_date":"2014-01-06","scope":"insider"},{"id":6685195,"accession":"0001354488-14-000060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001354488-14-000060","line_url":"/filing/0001354488-14-000060#line-1","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27400.0,"shares_display":"27,400","price_per_share":2.4557,"price_display":"2.46","price_state":"stated","total_value":67286.18,"total_display":"67,286.18","total_whole":"67,286","shares_owned_after":6332646.0,"shares_owned_after_display":"6,332,646","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-02","filed_date":"2014-01-06","scope":"insider"},{"id":5377038,"accession":"0001354488-13-006781","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001354488-13-006781","line_url":"/filing/0001354488-13-006781#line-2","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":2.2922,"price_display":"2.29","price_state":"stated","total_value":40113.5,"total_display":"40,113.50","total_whole":"40,114","shares_owned_after":6360046.0,"shares_owned_after_display":"6,360,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-06","filed_date":"2013-12-10","scope":"insider"},{"id":5377034,"accession":"0001354488-13-006781","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001354488-13-006781","line_url":"/filing/0001354488-13-006781#line-1","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19952.0,"shares_display":"19,952","price_per_share":2.3313,"price_display":"2.33","price_state":"stated","total_value":46514.0976,"total_display":"46,514.10","total_whole":"46,514","shares_owned_after":6377546.0,"shares_owned_after_display":"6,377,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-05","filed_date":"2013-12-10","scope":"insider"},{"id":4613146,"accession":"0001354488-13-006714","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001354488-13-006714","line_url":"/filing/0001354488-13-006714#line-3","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31019.0,"shares_display":"31,019","price_per_share":2.3824,"price_display":"2.38","price_state":"stated","total_value":73899.6656,"total_display":"73,899.67","total_whole":"73,900","shares_owned_after":6397498.0,"shares_owned_after_display":"6,397,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-04","filed_date":"2013-12-04","scope":"insider"},{"id":4613141,"accession":"0001354488-13-006714","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001354488-13-006714","line_url":"/filing/0001354488-13-006714#line-2","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7429.0,"shares_display":"7,429","price_per_share":2.4798,"price_display":"2.48","price_state":"stated","total_value":18422.4342,"total_display":"18,422.43","total_whole":"18,422","shares_owned_after":6428517.0,"shares_owned_after_display":"6,428,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-03","filed_date":"2013-12-04","scope":"insider"},{"id":4613134,"accession":"0001354488-13-006714","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001354488-13-006714","line_url":"/filing/0001354488-13-006714#line-1","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14100.0,"shares_display":"14,100","price_per_share":2.5454,"price_display":"2.55","price_state":"stated","total_value":35890.14,"total_display":"35,890.14","total_whole":"35,890","shares_owned_after":6435946.0,"shares_owned_after_display":"6,435,946","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-02","filed_date":"2013-12-04","scope":"insider"},{"id":5085175,"accession":"0001354488-13-006005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001354488-13-006005","line_url":"/filing/0001354488-13-006005#line-3","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30239.0,"shares_display":"30,239","price_per_share":1.9926,"price_display":"1.99","price_state":"stated","total_value":60254.2314,"total_display":"60,254.23","total_whole":"60,254","shares_owned_after":6450046.0,"shares_owned_after_display":"6,450,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-05","filed_date":"2013-11-05","scope":"insider"},{"id":5085172,"accession":"0001354488-13-006005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001354488-13-006005","line_url":"/filing/0001354488-13-006005#line-2","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15200.0,"shares_display":"15,200","price_per_share":2.0145,"price_display":"2.01","price_state":"stated","total_value":30620.4,"total_display":"30,620.40","total_whole":"30,620","shares_owned_after":6480285.0,"shares_owned_after_display":"6,480,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-04","filed_date":"2013-11-05","scope":"insider"},{"id":5085168,"accession":"0001354488-13-006005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001354488-13-006005","line_url":"/filing/0001354488-13-006005#line-1","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44561.0,"shares_display":"44,561","price_per_share":2.0137,"price_display":"2.01","price_state":"stated","total_value":89732.4857,"total_display":"89,732.49","total_whole":"89,732","shares_owned_after":6495485.0,"shares_owned_after_display":"6,495,485","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-01","filed_date":"2013-11-05","scope":"insider"},{"id":4245410,"accession":"0001354488-13-005587","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001354488-13-005587","line_url":"/filing/0001354488-13-005587#line-3","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":2.51,"price_display":"2.51","price_state":"stated","total_value":502.0,"total_display":"502.00","total_whole":"502","shares_owned_after":6540046.0,"shares_owned_after_display":"6,540,046","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-08","filed_date":"2013-10-08","scope":"insider"},{"id":4245405,"accession":"0001354488-13-005587","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001354488-13-005587","line_url":"/filing/0001354488-13-005587#line-2","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12379.0,"shares_display":"12,379","price_per_share":2.4865,"price_display":"2.49","price_state":"stated","total_value":30780.3835,"total_display":"30,780.38","total_whole":"30,780","shares_owned_after":6540246.0,"shares_owned_after_display":"6,540,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-07","filed_date":"2013-10-08","scope":"insider"},{"id":4245401,"accession":"0001354488-13-005587","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001354488-13-005587","line_url":"/filing/0001354488-13-005587#line-1","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10785.0,"shares_display":"10,785","price_per_share":2.4518,"price_display":"2.45","price_state":"stated","total_value":26442.663,"total_display":"26,442.66","total_whole":"26,443","shares_owned_after":6552625.0,"shares_owned_after_display":"6,552,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-04","filed_date":"2013-10-08","scope":"insider"},{"id":5302817,"accession":"0001354488-13-005551","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001354488-13-005551","line_url":"/filing/0001354488-13-005551#line-3","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25700.0,"shares_display":"25,700","price_per_share":2.4635,"price_display":"2.46","price_state":"stated","total_value":63311.95,"total_display":"63,311.95","total_whole":"63,312","shares_owned_after":6563410.0,"shares_owned_after_display":"6,563,410","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-03","filed_date":"2013-10-03","scope":"insider"},{"id":5302811,"accession":"0001354488-13-005551","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001354488-13-005551","line_url":"/filing/0001354488-13-005551#line-2","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13200.0,"shares_display":"13,200","price_per_share":2.5689,"price_display":"2.57","price_state":"stated","total_value":33909.48,"total_display":"33,909.48","total_whole":"33,909","shares_owned_after":6589110.0,"shares_owned_after_display":"6,589,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-02","filed_date":"2013-10-03","scope":"insider"},{"id":5302807,"accession":"0001354488-13-005551","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001354488-13-005551","line_url":"/filing/0001354488-13-005551#line-1","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Strategic Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27736.0,"shares_display":"27,736","price_per_share":2.6145,"price_display":"2.61","price_state":"stated","total_value":72515.772,"total_display":"72,515.77","total_whole":"72,516","shares_owned_after":6602310.0,"shares_owned_after_display":"6,602,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-01","filed_date":"2013-10-03","scope":"insider"},{"id":5546358,"accession":"0001387131-13-002242","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-13-002242","line_url":"/filing/0001387131-13-002242#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2631579.0,"shares_display":"2,631,579","price_per_share":1.75,"price_display":"1.75","price_state":"stated","total_value":4605263.25,"total_display":"4,605,263.25","total_whole":"4,605,263","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-06-14","filed_date":"2013-06-17","scope":"insider"},{"id":8970188,"accession":"0001354488-11-002326","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001354488-11-002326","line_url":"/filing/0001354488-11-002326#line-1","is_derivative":false,"issuer_cik":"0001024126","issuer_name":"PERNIX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"PTX","issuer_name_source":null,"issuer_url":"/issuer/0001024126","owner_cik":"0001485508","owner_name":"Collins Cooper C.","owner_display_name":"Collins Cooper C.","owner_url":"/insider/0001485508","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":498429.0,"shares_display":"498,429","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":3489003.0,"total_display":"3,489,003.00","total_whole":"3,489,003","shares_owned_after":8906571.0,"shares_owned_after_display":"8,906,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-07-21","filed_date":"2011-07-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":39,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":29,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":39},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000025743","name":"TherapeuticsMD, Inc.","url":"/issuer/0000025743","role":"Director","n_filings":9,"first_seen":"2013-06-17","last_seen":"2024-08-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001024126","name":"PERNIX THERAPEUTICS HOLDINGS, INC.","url":"/issuer/0001024126","role":"Director, Officer (Chief Strategic Officer), Ten percent owner","n_filings":11,"first_seen":"2011-07-25","last_seen":"2014-04-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001485508","retrieved_at":"2026-08-26T22:20:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}